Prenatal sonographic features of 22q 11.2 microdeletion syndrome

Journal of Medical Ultrasound

Volumn 16, Issue 2, 2008, Pages 123-129

  Chen, Chih Ping ^a,b   Chien, Shu Chin ^c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

de122q11.2; Prenatal ultrasound

Indexed keywords

AMNION FLUID; APLASIA; CHROMOSOME 22Q; CLEFT PALATE; CLINICAL FEATURE; CONGENITAL HEART MALFORMATION; ECHOGRAPHY; FACE MALFORMATION; FETUS CELL; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC DISORDER; GENETIC VARIABILITY; HUMAN; HYPOCALCEMIA; HYPOPLASIA; INTRAUTERINE GROWTH RETARDATION; LEARNING DISORDER; MEDICAL DECISION MAKING; MICRODELETION SYNDROME; NUCHAL TRANSLUCENCY MEASUREMENT; PALATOPHARYNGEAL INCOMPETENCE; PARATHYROID DISEASE; PERINATAL CARE; PHENOTYPE; POSTNATAL CARE; PRENATAL DIAGNOSIS; REVIEW; THYMUS DISEASE; URINARY TRACT MALFORMATION;

EID: 48049113696     PISSN: 09296441     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6441(08)60013-2     Document Type: Review

References (57)

1. Scambler PJ, Carey AH, Wyse RK, et al. Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome. Genomics 1991;10:201-6.
2. Driscoll DA, Spinner NB, Budarf ML, et al. Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am J Med Genet 1992;44:261-8.
3. Shprintzen RJ, Goldberg RB, Young B, et al. The velocardio-facial syndrome: a clinical and genetic analysis. Pediatrics 1981;67:167-72.
4. Matsuoka R, Takao A, Kimura M, et al. Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11.2. Am J Med Genet 1994;53:285-9.
5. Kitsiou-Tzeli S, Kolialexi A, Fryssira H, et al. Detection of 22q11.2 deletion among 139 patients with Di George/Velocardiofacial syndrome features. In Vivo 2004;18:603-8.
6. Berend SA, Spikes AS, Kashork CD, et al. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci. Am J Med Genet 2000; 91:313-7.
7. Driscoll DA, Salvin J, Sellinger B, et al. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J Med Genet 1993; 30:813-7.
8. Hou JW, Wang JK, Tsai WY, et al. CATCH 22: deletion of locus 22q11 in velocardiofacial syndrome, DiGeorge anomaly, and nonsyndromic conotruncal defects. J Formos Med Assoc 1997;96:419-23.
9. Wilson DI, Burn J, Scambler P, et al. DiGeorge syndrome: part of CATCH 22. J Med Genet 1993;30: 852-6.
10. Lindsay EA, Greenberg F, Shaffer LG, et al. Submicroscopic deletions at 22q11.2: variability of the clinical picture and delineation of a commonly deleted region. Am J Med Genet 1995;56:191-7.
11. Devriendt K, Fryns JP, Mortier G, et al. The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet 1998;35:789-90.
12. Tezenas Du Montcel S, Mendizabai H, Ayme S, et al. Prevalence of 22q11 microdeletion. J Med Genet 1996; 33:719.
13. Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 2007; 370:1443-52.
14. Driscoll DA, Budarf ML, Emanuel BS. Antenatal diagnosis of DiGeorge syndrome. Lancet 1991;338:1390-1.
15. Van Hemel JO, Schaap C, Van Opstal D, et al. Recurrence of DiGeorge syndrome: prenatal detection by FISH of a molecular 22q11 deletion. J Med Genet 1995;32:657-8.
16. Davidson A, Khandelwal M, Punnett HH. Prenatal diagnosis of the 22q11 deletion syndrome. Prenat Diagn 1997;17:380-3.
17. Devriendt K, Thienen MN, Swillen A, et al. Cerebellar hypoplasia in a patient with velo-cardio-facial syndrome. Dev Med Child Neurol 1996;38:949-53.
18. Nickel RE, Pillers BA, Merkens M, et al. Velo-cardiofacial syndrome and DiGeorge sequence with meningomyelocele and deletions of the 22q11 region. Am J Med Genet 1994;52:445-9.
19. Volpe P, Marasini M, Caruso G, et al. 22q11 deletions in fetuses with malformations of the outflow tracts or interruption of the aortic arch: impact of additional ultrasound signs. Prenat Diagn 2003;23: 752-7.
20. Cormier-Daire V, Iserin L, Theophile D, et al. Upper limb malformations in DiGeorge syndrome. Am J Med Genet 1995;56:39-41.
21. Levy-Mozziconacci A, Wernert F, Scambler P, et al. Clinical and molecular study of DiGeorge sequence. Eur J Pediatr 1994;153:813-20.
22. Digilio MC, Marino B, Bagolan P, et al. Microdeletion 22q11 and oesophageal atresia. J Med Genet 1999; 36:137-9.
23. Minier F, Carles D, Pelluard F, et al. DiGeorge syndrome, a review of 52 patients. Arch Pediatr 2005;12: 254-7. [In French]
24. Machlitt A, Tennstedt C, Korner H, et al. Prenatal diagnosis of 22q11 microdeletion in an early second-trimester fetus with conotruncal anomaly presenting with increased nuchal translucency and bilateral intracardiac echogenic foci. Ultrasound Obstet Gynecol 2002; 19:510-3.
25. Oh DC, Min JY, Lee MH, et al. Prenatal diagnosis of tetralogy of Fallot associated with chromosome 22q11 deletion. J Korean Med Sci 2002;17:125-8.
26. Motzkin B, Marion R, Goldberg R, et al. Variable phenotypes in velocardiofacial syndrome with chromosomal deletion. J Pediatr 1993;123:406-10.
27. Van Mierop LH, Kutsche LM. Cardiovascular anomalies in DiGeorge syndrome and importance of neural crest as a possible pathogenetic factor. Am J Cardiol 1986;58:133-7.
28. Young D, Shprintzen RJ, Goldberg RB. Cardiac malformations in the velocardiofacial syndrome. Am J Cardiol 1980;46:643-8.
29. Goldmuntz E, Driscoll D, Budarf ML, et al. Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects. J Med Genet 1993;30:807-12.
30. Iserin L, de Lonlay P, Viot G, et al. Prevalence of the microdeletion 22q11 in newborn infants with congenital conotruncal cardiac anomalies. Eur J Pediatr 1998;157:881-4.
31. Boudjemline Y, Fermont L, Le Bidois J, et al. Prevalence of 22q11 deletion in fetuses with conotruncal cardiac defects: a 6-year prospective study. J Pediatr 2001; 138:520-4.
32. Chaoui R, Kalache KD, Heling KS, et al. Absent or hypoplastic thymus on ultrasound: a marker for deletion 22q11.2 in fetal cardiac defects. Ultrasound Obstet Gynecol 2002;20:546-52.
33. Momma K, Kondo C, Matsuoka R, et al. Cardiac anomalies associated with a chromosome 22q11 deletion in patients with conotruncal anomaly face syndrome. Am J Cardiol 1996;78:591-4.
34. Momma K, Kondo C, Matsuoka R. Tetralogy of Fallot with pulmonary atresia associated with chromosome 22q11 deletion. J Am Coll Cardiol 1996;27:198-202.
35. Marino B, Digilio MC, Toscano A, et al. Anatomic patterns of conotruncal defects associated with deletion 22q11. Genet Med 2001;3:45-8.
36. Consevage MW, Seip JR, Belchis DA, et al. Association of a mosaic chromosomal 22q11 deletion with hypoplastic left heart syndrome. Am J Cardiol 1996;77: 1023-5.
37. Yates RW, Raymond FL, Cook A, et al. Isomerism of the atrial appendages associated with 22q11 deletion in a fetus. Heart 1996;76:548-9.
38. Goldmuntz E, Clark BJ, Mitchell LE, et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 1998;32:492-8.
39. Levy-Mozziconacci A, Lacombe D, Leheup B, et al. Microdeletion of the chromosome 22q11 in children: apropos of a series of 49 patients. Arch Pediatr 1996; 3:761-8. [In French]
40. Chaoui R. Fetal echocardiography: state of the art of the state of the heart. Ultrasound Obstet Gynecol 2001; 17:277-84.
41. Felker RE, Cartier MS, Emerson DS, et al. Ultrasound of the fetal thymus. J Ultrasound Med 1989;8:669-73.
42. Zalel Y, Gamzu R, Mashiach S, et al. The development of the fetal thymus: an in utero sonographic evaluation. Prenat Diagn 2002;22:114-7.
43. Chaoui R, Korner H, Bommer C, et al. Fetal thymus and the 22q11.2 deletion. Prenat Diagn 2002;22: 839-40.
44. Chen M, Hwu WL, Kuo SJ, et al. Subtelomeric rearrangements and 22q11.2 deletion syndrome in anomalous growth-restricted fetuses with normal or balanced G-banded karyotype. Ultrasound Obstet Gynecol 2006;28:939-43.
45. Devriendt K, Swillen A, Fryns JP, et al. Renal and urological tract malformations caused by a 22q11 deletion. J Med Genet 1996;33:349.
46. Goodship J, Robson SC, Sturgiss S, et al. Renal abnormalities on obstetric ultrasound as a presentation of DiGeorge syndrome. Prenat Diagn 1997;17:867-70.
47. Demczuk S, Aurias A. DiGeorge syndrome and related syndromes associated with 22q11.2 deletions. A review. Ann Genet 1995;38:59-76.
48. Hyett J, Perdu M, Sharland G, et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 1999;318:81-5.
49. Hyett JA, Perdu M, Sharland GK, et al. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol 1997;10:242-6.
50. Nicolaides KH, Azar G, Snijders RJ, et al. Fetal nuchal oedema: associated malformations and chromosomal defects. Fetal Diagn Ther 1992;7:123-31.
51. Lazanakis MS, Rodgers K, Economides DL. Increased nuchal translucency and CATCH 22. Prenat Diagn 1998;18:507-10.
52. Zosmer N, Souter VL, Chan CS, et al. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. Br J Obstet Gynaecol 1999;106:829-33.
53. Donnenfeld AE, Cutillo D, Horwitz J, et al. Prospective study of 22q11 deletion analysis in fetuses with excess nuchal translucency. Am J Obstet Gynecol 2006;194: 508-11.
54. Hollis B, Mavrides E, Carvalho JS, et al. Significance of chromosome 22q11 analysis after detection of an increased first-trimester nuchal translucency. Ultrasound Obstet Gynecol 2001;18:32-4.
55. Devriendt K, Van Schoubroeck D, Eyskens B, et al. Polyhydramnios as a prenatal symptom of the digeorge/velo-cardio-facial syndrome. Prenat Diagn 1998;18: 68-72.
56. Lipson AH, Yuille D, Angel M, et al. Velocardiofacial (Shprintzen) syndrome: an important syndrome for the dysmorphologist to recognise. J Med Genet 1991; 28:596-604.
57. McLean SD, Saal HM, Spinner NB, et al. Velo-cardio-facial syndrome. Intrafamilial variability of the phenotype. Am J Dis Child 1993;147:1212-6.